Studies how minor stroke patients may recover quality of life over time
Tests whether early patient details can predict quality of life after a minor ischemic stroke.
Plain-language title generated from the registry record
Registry title: BREMISS : Brain Resilience Minor Stroke Study
Key facts
- Where
- Brest, FranceSee the site
Where in France
- CHU de BrestBrest, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Brest
- Trial code
- NCT06995040
- Record updated
- 23 February 2026
- Original description
The objective of this clinical trial is to develop, based on patients' initial characteristics (in the first few weeks following the stroke), a predictive model of quality of life more than 4 years after the stroke in patients who have suffered a minor ischemic stroke.Read full original descriptionShow less
Initial Predictors of Long-term Brain Resilience After Minor Ischemic Stroke: a Study Nested in the Brest Stroke Population-based Registry
The objective of this clinical trial is to develop, based on patients' initial characteristics (in the first few weeks following the stroke), a predictive model of quality of life more than 4 years after the stroke in patients who have suffered a minor ischemic stroke.
The main question it aims to answer is:
- Is it possible to predict the quality of life of patients who have suffered a minor ischemic stroke based on their initial characteristics?
To do this, retrospective and prospective data collected as part of the study will be analyzed using a conventional statistical approach and algorithms based on AI approaches in order to create a predictive model.
Participants will be asked to:
* Complete questionnaires * Provide a saliva sample (optional) * Undergo an MRI scan (optional)
Inclusion: Cases of stroke in the Brest Stroke Registry (BSR); Ability to sign informed consent; Patients followed-up > 4 years during the study period; NIHSS score ≤ 5 on admission; First stroke above 18 and before 75-year old; Rankin before stroke < 1; Possibility to draw saliva samples for genomic study; Possibility to perform Cerebral MRI.
Exclusion: Patients with transient neurological deficits resolving within one hour and normal brain imaging will be excluded; Not affiliated to social security; Patient under legal protection or deprived of liberty by a judicial or administrative decision; Patient unable to sign informed consent; Patient whose follow-up will be impossible.